NASDAQ:PETS - Petmed Express Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$40.19 -1.18 (-2.85 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$41.37
Today's Range$39.86 - $41.45
52-Week Range$31.81 - $57.80
Volume804,282 shs
Average Volume633,190 shs
Market Capitalization$839.47 million
P/E Ratio22.08
Dividend Yield2.45%
Beta0.98
Petmed Express logoPetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio5.81
Quick Ratio4.52

Price-To-Earnings

Trailing P/E Ratio22.08
Forward P/E Ratio17.63
P/E Growth1.79

Sales & Book Value

Annual Sales$273.80 million
Price / Sales3.02
Cash Flow$1.8860 per share
Price / Cash21.31
Book Value$5.62 per share
Price / Book7.15

Profitability

EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins13.62%
Return on Equity34.76%
Return on Assets28.63%

Miscellaneous

Employees187
Outstanding Shares20,600,000
Market Cap$839.47

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Monday, May 7th. Investors of record on Friday, May 18th will be given a dividend of $0.25 per share on Friday, May 25th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date is Thursday, May 17th. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) released its quarterly earnings data on Monday, May, 7th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.47 by $0.03. The company earned $67.30 million during the quarter, compared to the consensus estimate of $68.43 million. Petmed Express had a net margin of 13.62% and a return on equity of 34.76%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

6 equities research analysts have issued twelve-month price objectives for Petmed Express' shares. Their forecasts range from $19.00 to $58.00. On average, they expect Petmed Express' share price to reach $39.00 in the next twelve months. This suggests that the stock has a possible downside of 3.0%. View Analyst Ratings for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Has Petmed Express been receiving favorable news coverage?

Media stories about PETS stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Petmed Express earned a news sentiment score of 0.16 on Accern's scale. They also assigned news coverage about the company an impact score of 46.25 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include North Star Investment Management Corp. (0.54%), Fisher Asset Management LLC (0.51%), Scout Investments Inc. (0.39%), Capital One National Association (0.11%), Boston Advisors LLC (0.10%) and Bank of Montreal Can (0.08%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Municipal Employees Retirement System of Michigan and Capital One National Association. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., North Star Investment Management Corp., Boston Advisors LLC, Hartford Investment Management Co., Xact Kapitalforvaltning AB, Bank of Montreal Can and Tokio Marine Asset Management Co. Ltd.. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $40.19.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $839.47 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  255 (Vote Underperform)
Total Votes:  374
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Featured Article: What are CEFs?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.